DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1 by Paredes-Juarez, Genaro A. et al.
  
 University of Groningen
DAMP production by human islets under low oxygen and nutrients in the presence or
absence of an immunoisolating-capsule and necrostatin-1
Paredes-Juarez, Genaro A.; Sahasrabudhe, Neha M.; Tjoelker, Reina S.; de Haan, Bart J.;





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2015
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Paredes-Juarez, G. A., Sahasrabudhe, N. M., Tjoelker, R. S., de Haan, B. J., Engelse, M. A., de Koning, E.
J. P., ... de Vos, P. (2015). DAMP production by human islets under low oxygen and nutrients in the
presence or absence of an immunoisolating-capsule and necrostatin-1. Scientific Reports, 5, [14623].
https://doi.org/10.1038/srep14623
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
1Scientific RepoRts | 5:14623 | DOi: 10.1038/srep14623
www.nature.com/scientificreports
DAMP production by human islets 
under low oxygen and nutrients 
in the presence or absence of an 
immunoisolating-capsule and 
necrostatin-1
Genaro A. Paredes-Juarez1, Neha M. Sahasrabudhe1, Reina S. Tjoelker1, Bart J. de Haan1, 
Marten A. Engelse2, Eelco J. P. de Koning2, Marijke M. Faas1 & Paul de Vos1
In between the period of transplantation and revascularization, pancreatic islets are exposed to 
low-oxygen and low-nutrient conditions. In the present study we mimicked those conditions in vitro 
to study the involvement of different cell death processes, release of danger-associated molecular 
patterns (DAMP), and associated in vitro immune activation. Under low-oxygen and low-nutrient 
conditions, apoptosis, autophagy and necroptosis occur in human islets. Necroptosis is responsible 
for DAMP-release such as dsDNA, uric acid, and HMGB1. The sensors of the innate immune system 
able to recognize these DAMPs are mainly TLR, NOD receptors, and C-type lectins. By using cell-lines 
with a non-functional adaptor molecule MyD88, we were able to show that the islet-derived DAMPs 
signal mainly via TLR. Immunoisolation in immunoprotective membranes reduced DAMP release 
and immune activation via retention of the relative large DAMPs in the capsules. Another effective 
strategy was suppressing necroptosis using the inhibitor nec-1. Although the effect on cell-survival 
was minor, nec-1 was able to reduce the release of HMGB1 and its associated immune activation. Our 
data demonstrate that in the immediate post-transplant period islets release DAMPs that in vitro 
enhance responses of innate immune cells. DAMP release can be reduced in vitro by immunoisolation 
or intervention with nec-1.
Islet transplantation has the potential to supply patients with type 1 diabetes with an endogenous insulin 
source that regulates the glucose levels on a minute-to-minute level. A major breakthrough was reported 
in 2000 when insulin independence in a series of seven patients for a period of a year was reported1. 
Despite this breakthrough, the approach has not yet reached the stage of large-scale clinical application. 
The reasons for this is the shortage of organ donors and the relative short duration of graft survival 
with inevitable lost in functionality. Two years after transplantation, less than 50% of the patients is still 
insulin-independent2 and five years following transplantation this percentage is not more than 10%3. 
Although during recent years some groups have been more successful4, the overall conclusion has to 
be that many factors remain to be improved in the islet-transplantation procedures before large-scale 
clinical application is a realistic option.
During recent years many groups have focused on the identification of factors determining success 
or failure of islet grafts. Factors that have been implicated in the low success rates are the instant blood 
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mediated inflammatory reaction5–7, alloreactivity5, recurrent autoimmunity5, NK-cell cytotoxicity8, inad-
equacy of the liver as transplantation site9, local and systemic T cell responses and macrophage recruit-
ment10, and insufficient revascularization11. In most cases, however, the focus has been on external, host 
factors that influence islet-survival and not on mechanisms by which the islets themselves contribute to 
their own destruction. Islets are potent producers of all types of bioactive molecules and may enhance 
inflammatory responses against themselves11.
Danger-associated molecular patterns (DAMPs) are molecules from the intracellular space that upon 
release to the extracellular space are recognized as alarm signals12. DAMPs can induce severe inflam-
mation and are part of the pathogenesis of aseptic or sterile inflammation13. DAMPs are recognized by 
pattern recognition receptors (PRRs), mainly by Toll-like receptors (TLRs), and induce an inflammation 
cascade even when present in low amounts14,15. Examples of DAMPs are high mobility group box 1 
protein (HMGB1) that in normal conditions play a role in the winding of DNA and promotes assembly 
of proteins12,16. Another example is heat shock protein 70 (HSP70) that has been implicated in failure of 
transplanted kidneys17. HSP70 effectively promotes recruitment of immune cells17–19. Other molecules 
that are studied and have been identified as DAMPs are uric acid and DNA-fragments14.
DAMPs are released during ischemia-reperfusion damage20 as the consequence of cells that die by 
necrosis and necroptosis15,18,21,22. As islets undergo a relative long phase of ischemia in between the 
period of implantation and revascularization it is plausible that also DAMPs play a role in islet-graft fail-
ure23. It has also been demonstrated that islets are able to release the monocyte chemoattractant protein-1 
(MCP-1) which influencing the survival of grafts24. Indeed, in transplantation-research, it becomes cur-
rently recognized that DAMPs might play a crucial role in the responses against grafts14. However, to our 
best knowledge, DAMPs produced by islets have not been studied in detail.
Therefore, in the present study human pancreatic islets were subjected to suboptimal culture con-
ditions mimicking the circumstances islets meet directly after transplantation. To this end, islets were 
cultured under hypoxic conditions or low-nutrient conditions to mimic the phase in which islets are 
not vascularized. Normal culture conditions served as control. The release of DAMPs was studied at 
day 1 and 7 after the start culture, which are critical days for graft loss after transplantation in vivo11. 
The DAMPs, HMGB1, DNA and uric acid were measured in the culture supernatant. Moreover, culture 
supernatants were co-incubated with a THP1 reporter cell-line expressing TLRs and a THP1 cell-line 
with a truncated and inactive MyD88 signaling pathway. These experiments were also done with islets 
immunoisolated in alginate-PLL-alginate (APA) capsule and a necroptosis inhibitor to investigate the 
efficacy of encapsulation or pharmaceutical intervention in preventing DAMP-induced immune activa-
tion by human pancreatic islets.
Results
Islet-derived molecules contribute to TLR-dependent immune activation. In order to inves-
tigate whether supernatant of islets cultured under the combination of low nutrients and or hypoxia 
induce immune activation, the supernatant of pancreatic islets were co-incubated with THP1-XBlue™ 
-MD2-CD14 cell-line. This cell-line contains all TLRs as well as other PRRs25,26. To study whether the 
signaling is dependent on TLRs, and not on other PRRs, we subsequently tested the supernatants on a 
THP1 cell expressing a non-functional form of the TLR adapter MyD88 (Supplemental Fig. S1).
As shown in Fig. 1, even under control conditions immune-activation of THP1-XBlue™-MD2-CD14 
was observed at 1 day (Fig. 1a). This activation was more enhanced by low-nutrient conditions than by 
hypoxia. The effect of low-nutrient conditions was reduced after 7 days of culturing (Fig. 1b) (p < 0.05). 
The reduction, can be explained by survival of a lower number of islet-cells that contribute to DAMPs 
production as will be presented in the next section, in which almost 40% of the cells are lost due to 
the harsh culture circumstances. The activation was TLR-dependent as the activation was profoundly 
reduced when the same supernatant was co-incubated with THP1 cells expressing the non-functional 
MyD88 under combined hypoxic and low-nutrient conditions (Fig. 1c,d).
Viability and cell-death processes involved. To determine the loss of islet-cells as the consequence 
of the different culture conditions the nuclear DNA on day 1 and 7 was studied as a measure for sur-
viving cells. Under normal control conditions and low-nutrient exposure in normoxic conditions an 
approximate reduction of 35.45 ± 1.97% and 35.43 ± 3.91% of the cells was observed. This reduction 
was 31.43 ± 5.43% under hypoxia but normal nutrient conditions and when islets were exposed to the 
combination hypoxia and low-nutrient conditions a reduction of 32.15 ± 5.27% was observed (Fig.  2). 
All the reductions in nuclear DNA were statistically significant (p < 0.001).
Islets were subsequently subjected to studies for autophagy and apoptosis (Fig.  3). The autophagy 
TR-FRET assay serves to quantify autophagosomes in islets27. As shown in Fig. 3a, islets cultured under 
low-nutrient and hypoxic conditions have almost twice as much autophagic bodies (EC50 = 43.5) when 
compared to control conditions (EC50 = 23.5). Primary apoptosis was quantified by counting the num-
ber of Annexin V positive cells and was found to be statistically significant enhanced by low-nutrient 
hypoxic conditions (p < 0.05) (Fig.  3c) but not by control normoxic conditions (Fig.  3b). As Annexin 
V staining identifies apoptotic cells in an early stage, the islets were also subjected to caspase-3 and − 9 
analysis by western blot, to demonstrate the more irreversible stage of apoptosis28. After incubation under 
low-nutrients hypoxic and control normoxic conditions, full caspase-3 and − 9 was found but not their 
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Figure 1. TLR dependency of the activation of THP1 cells by islet derived molecules. THP1 cells were 
stimulated with supernatant of human islets incubated for 1 (a) and 7 (b) days under control and low-
nutrition conditions at 20% and 1% of oxygen. NF-κ B/AP-1 activation was enhanced under low-nutrients and 
low oxygen conditions in a TLR fashion, since this activation was virtually absent in THP1 MyD88-deficient 
cell lines at 1 (c) or 7 (d) days of incubation. Values are presented as median ± IQR (n = 4 separate batches of 
human islets). A p < 0.05 was consider statistical significant (*p < 0.05; **p < 0.01). LPS (10 μ g/ml) and Tri-
DAP (10 μ g/ml) were used as positive control for THP1 and THP1 MyD88-deficient cell lines respectively.
Figure 2. Nuclear DNA content of human islet cultures. DNA was quantified after isolation of nuclei 
of cultured islets. Islets were incubated for 1 and 7 days under control conditions or under low nutrient 
condition in combination with 20% or 1% of oxygen. Values are presented as median ± IQR (n = 4 separate 
batches of human islets). A p < 0.05 was considered statistical significant (***p < 0.001).
www.nature.com/scientificreports/
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cleaved form (Fig.  3d). This indicates an active process of cellular death towards necrosis rather than 
secondary apoptosis29,30.
Release of DAMPs is a mean for quantification of the involvement of necrosis and necroptosis18,22,23. 
The most commonly studied DAMPs in necrosis or necroptosis are heat shock protein 70 (HSP70), dou-
ble stranded DNA (dsDNA), uric acid, and high mobility group box 1 (HMGB1)19,21,22. In none of the 
conditions tested we observed HSP70 release. This was different with HMGB1, uric acid, and dsDNA. 
These DAMPs were constitutively present in culture media even under control conditions. HMGB1 
release was found under all culture conditions without any significant difference between different cul-
ture conditions (Fig. 4a,b). This release is possibly due to loss in cell-viability.
The dsDNA concentration increased significantly (p < 0.01) after 1 day of hypoxic culture under low 
nutrients when compared with control conditions (Fig. 4c). Also, after culture for 7 days under hypoxic 
conditions (Fig. 4d), low values of dsDNA can be observed, this can be explained again by a lower num-
ber of cells surviving the severe conditions.
Uric acid was present under all conditions but was not statistically significant enhanced by low nutri-
ent or hypoxic conditions (Fig. 4e,f).
Immunoisolation of pancreatic islets reduce immune activation. Immunoisolation as a mean 
to prevent rejection of islets is gaining much attention by the scientific community7,9. DAMPs are rel-
atively large structures that should be retained by the membranes. To confirm this, human islets were 
encapsulated in alginate-PLL-alginate (APA) capsules and cultured under the same low-nutrient and 
Figure 3. Autophagy and apoptosis in human pancreatic islets. TR-FRET acceptor in human islets 
incubated under control conditions in normoxia or under low nutrient conditions and hypoxia (a). Assay 
windows values are plotted as mean (n = 2 duplicate wells for each concentration of CQ). Percentage of 
apoptotic islets were calculated as positive islets stained with Annexin V cultured in control normoxic 
conditions and (b) or hypoxic low nutrients (c). Representative western blot picture for caspase-3 and − 9 
(d). Values are presented as median ± IQR. A p < 0.05 was considered significant (*p < 0.05).
www.nature.com/scientificreports/
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hypoxic conditions. Supernatant was subsequently incubated with THP1-XBlue™-MD2-CD14. The 
induced responses were up to tenfold lower when compared to free islets after 1 day of incubation under 
all the different conditions (supplemental Fig. S2) indicating that encapsulation prevents the release of 
some DAMPs. To confirm that, we quantified the release of DAMPs by encapsulated islets after incuba-
tion. Interestingly, HMGB1 was absent under all incubation conditions. We detected dsDNA under low 
(Fig.  5a) or normal nutrient conditions (Fig.  5b), and under hypoxia or normoxia, with no statistical 
significant differences. Uric acid was statistically significant increased (p < 0.05) on day 1 and 7 under 
all the conditions with low nutrient availability (Fig. 5c,d).
Figure 4. Danger-associated molecular patterns (DAMPs) released by free human islets. Human islets 
were incubated for 1 (a,c,e) or 7 (b,d,f) days under control and low nutrient conditions at 20% and 1% of 
oxygen. DAMPs produced by islets were high mobility group protein B1 (HMGB1; (a,b)), double stranded 
DNA (dsDNA; (c,d)), and uric acid (e,f). Values are presented as median ± IQR (n = 4 separate batches of 
human islets). A p < 0.05 was considered statistically significant (**p < 0.01).
www.nature.com/scientificreports/
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Necrostatin -1 promotes cell survival and reduces DAMPs release. Since necroptosis is one of 
the main cell-death processes responsible for release of DAMPs, we studied the effect of nec-1, a potent 
inhibitor of necroptosis22, on cell survival after 7 days of culture in the different conditions. At day 0, 
islets contained 279.54 ± 37.39 ng/ml of nuclear DNA. The DNA content decreased under the different 
culture conditions, which could partly be prevented by addition of nec-1 to the capsules. This how-
ever only reached statistical significance when cultured in 1% of oxygen in the presence or absence of 
low-nutrient conditions when compared with day 0 (Fig. 6).
To determine whether nec-1 addition also reduces immune activation and DAMPs release, the effects 
where studied on THP1 cells and on DAMP production. Supernatant of encapsulated islets treated with 
nec-1 provoked a lower NF-κ B activation in THP1 cells than the non-treated encapsulated islets. This 
was observed under low nutrition conditions combined with normoxia and in low nutrition conditions 
under hypoxia when compared with free islets after 1 day of incubation (supplemental Fig. S3). This 
reduction in immune-activation was associated with lower release (p < 0.05) of the DAMP dsDNA also 
under low-nutrients and hypoxic conditions after 1 and 7 days of incubation (Fig. 7a,b). Uric acid was 
also reduced (p < 0.001) by nec-1 at 1 day of incubation under low-nutrients and hypoxic conditions 
(Fig. 7c).
Discussion
In between the period of transplantation and revascularization, islets are exposed to suboptimal condi-
tions with low availability of oxygen and nutrients. Here we show, to our best knowledge for the first 
Figure 5. Reduction of danger-associated molecular patterns (DAMPs) from immunoisolated islets in 
alginate-based microcapsules. Supernatant of encapsulated pancreatic human islets incubated for 1 (a,c) 
and 7 (b,d) days under control and low nutrients conditions at 20% and 1% of oxygen. DAMPs found were 
double stranded DNA (dsDNA; (a,b)), and uric acid (c,d). High mobility group protein B1 (HMGB1) was 
not found in encapsulated islets and therefore not shown in the graph. Values are presented as median ± IQR 
(n = 4 separate batches of human islets). a p < 0.05 was consider statistical significant (*p < 0.05; **p < 0.01).
www.nature.com/scientificreports/
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Figure 6. Comparison of nuclear DNA content between encapsulated islets with or without nec-1. 
Nuclei of control encapsulated and encapsulated nec-1 human islets were isolated for quantification of DNA 
before and after incubation for 7 days under control and low nutrients at 20% and 1% of oxygen. Human 
islets encapsulated in conventional APA system contained statistical significantly lower amounts of DNA 
after incubation under control and low nutrients at 1% of oxygen (*p < 0.05) when compared with capsules 
at day 0. Values are presented as median ± IQR (n = 4 separate batches of human islets).
Figure 7. Reduction of danger-associated molecular patterns (DAMPs) by nec-1 in encapsulated human 
islets. Supernatant of encapsulated human islets with nec-1 incubated for 1 (a,c) and 7 (b,d) days under 
control and low nutrients at 20% and 1% of oxygen. DAMPs found were double stranded DNA (dsDNA; 
(a,b)), and uric acid (c,d). DsDNA was normalized. High mobility group protein B1 (HMGB1) was not 
found in supernatant of encapsulated islets and is therefore not shown in the graph. Values are presented 
as median ± IQR (n = 4 separate batches of human islets). a p < 0.05 was consider significant (*p < 0.05; 
**p < 0.01).
www.nature.com/scientificreports/
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time, that under these circumstances not only apoptosis and necrosis but also autophagy and necroptosis 
occur in islets. Autophagy can be induced by the same factors that induce apoptosis, i.e. nutrient depri-
vation, but with different consequences. Apoptosis normally does not induce inflammation while auto-
phagic bodies can interact with antigen presenting cells (APCs) to induce immune responses19. However, 
our data suggest that primary apoptosis in islet-cells may also lead to immune activation since we show 
that hypoxia-induced primary apoptosis in islets present the non-cleaved caspase-9 and − 3 but not their 
cleaved products. This indicates an active process of cellular dead towards necrosis rather than secondary 
apoptosis29,30. This will lead to inflammation-inducing DAMPs. Thus, our data suggest that all cell-death 
processes including apoptosis in the islets may contribute to inflammation. The final result is always 
loss of functional cell-mass and release of inflammatory components from the intracellular space, i.e. 
DAMPs. This is to our opinion an important observation as strategies to prevent islet-loss by suppressing 
apoptosis or autophagy will have less effect than suppressing necrosis and necroptosis.
To determine the loss of islet-cells as the consequence of the harsh culture conditions, we first deter-
mined the DNA content of the islets at day 1 and 7. This was done initially by measuring the total-DNA 
and not by measuring nuclear DNA. In these initial experiments with total DNA we could not detect 
any DNA-reduction in the cultures even under very harsh low-oxygen and low-nutrition conditions. We 
contemplated that total DNA might be an inadequate measure for cell-numbers in islets due to presence 
of free DNA released by necrotic cells. Therefore we applied in the present study a two-step approach. We 
first isolated the nucleus from surviving cells and performed a DNA-quantification on the nuclei, repre-
senting intact cells. A comparison with total-DNA confirmed that total DNA did not reflect the number 
of surviving cells (data not shown) after which we only applied nuclear DNA for quantifying surviving 
islet cells. Notably, many studies might suffer from an overestimation of viable cells in islets as total-DNA 
is the golden standard in studies on glucose-induced insulin release1,31. Unfortunately we cannot do these 
types of measurements on small numbers of islets as the consequence of which we cannot express the 
DAMP production per unit of DNA.
Our study demonstrates that human pancreatic islets are potent producers of DAMPs such as dsDNA, 
uric acid, and HMGB1. HSP70, a potent inflammatory DAMP17, was not released by islets. The dsDNA 
is recognized by TLR918,32,33 an inducer of antibodies and CD8+ T-cell responses18. Uric acid can be 
recognized by TLR2 and 4 but has also been reported to be responsible for destruction of beta-cells 
and suppression of basal insulin release34. HMBG1, a DNA transcriptional regulator, triggers immune 
responses by forming complexes with other molecules and binding combinations of PRRs such as TLR2/
TLR4 and the receptor for advanced glycosylation end products (RAGE)16. The release of these DAMPs 
by islets was more pronounced in low-nutrient conditions than under hypoxia.
As many DAMPs are large molecules that cannot readily pass immunoisolating membranes we inves-
tigated the effect of encapsulation on DAMP-release and immune-activation. This reducing effect was 
profound but dependent on the type of DAMP studied. After encapsulation a reduction in DAMP-release 
in the medium was observed and a tenfold reduction in NF-κ B activation. Concomitantly a reduction 
of HMGB1 release was observed. HMGB1 was undetectable after encapsulation of the islets. DsDNA 
was less reduced but retained as it was found throughout the capsules. Also nec-1 addition was an effec-
tive way to reduce DAMP release and immune activation in THP1 cells. The effects on cell loss were 
less pronounced than on DAMP release. This should be explained that some of the cells will probably 
die due to other cell-death processes than necroptosis35. Nec-1 suppresses the expression of the serine/
threonine-protein kinases 1 and 3 (RIPK1 ad 3)22,36, i.e. two essential proteins for necroptosis induction. 
Our data demonstrate that this is an effective strategy as illustrated by a higher viability of the islets, a 
twofold reduction of NF-κ B dependent immune activation under combined hypoxic and low-nutrient 
conditions.
Conclusions
To our best knowledge, this is the first study dedicated to release of DAMPs by human pancreatic islets. 
Culturing human islets under the circumstances that islets may meet in the period between transplan-
tation and vascularization induced the release of HMGB1, dsDNA, and uric acid. From these mole-
cules it is known that they can induce a MyD88-TLR dependent immune response. Our data suggest 
that the use of immunoprotective membranes is efficacious in reducing DAMPs release and associated 
MyD88-dependent immune responses. Also, nec-1 administration might be an efficacious strategy to 
reduce DAMP release and associated immune activation in the immediate period after transplantation.
Research Design and Methods
Human islet isolation. Human islets were isolated from cadaveric pancreata at the Leiden University 
Medical Center, as previously described37,38. Islets were used if quality and/or number was insufficient for 
clinical application, according to national laws, and if research consent was available. All donor organs 
are coded (anonymized). Isolated islets were cultured as previously described39. All the methods and 
experimental protocols were approved and carried out in accordance with the Code of Proper Secondary 
Use of Human Tissue in The Netherlands as formulated by the Dutch Federation of Medical Scientific 
Societies. The Leiden University Medical Center has permission from the Dutch government to act as 
an organ bank for human islets. The organs, for which consent for research was obtained, were allocated 
by the Eurotransplant Foundation (Leiden, The Netherlands).
www.nature.com/scientificreports/
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Islet encapsulation. Intermediate-G alginate (ISP Alginates Ltd UK) has been purified and used40. 
Only highly purified alginates were applied as described before41. All the solutions were sterilized by 
filtration (0.2 μ m pore size). Islets were suspended in purified alginate solution (3.4% w/v) at a concentra-
tion of 1000 islets/ml. The alginate-PLL-alginate (APA) capsules were formed as previously described26. 
The capsules had a final diameter of 650–700 μ m.
In some experiments, for inhibition of necroptosis 100 μ M of necrostatin-1 (nec-1) (Merck Chemicals, 
Darmstadt, Germany) was added to the alginate solution before encapsulation and incubation.
To measure DNA content, the capsules around the islets needed to be removed. To this end, the cap-
sules were incubated with trypsin-EDTA-PBS buffer (TEP, 0.5% trypsin (v/v), 0.5 mM EDTA in PBS 1x 
pH 7.4) at 37 °C under constant shaking for 30 min.
Experimental culture conditions. Islets (encapsulated or non-encapsulated) were exposed to differ-
ent experimental conditions to mimic the conditions they may encounter in vivo. To mimic the relative 
low oxygen tensions after transplantation9,42, islets were cultured under hypoxic conditions (1% O2, 5% 
CO2, and 94% N2). Normoxic (20% O2, 5% CO2, and 75% N2) conditions served as control. Insufficient 
revascularization after implantation of islets can also lead to low nutrition43. To simulate low nutrition, 
islets were cultured without fetal calf serum (FCS) in CMRL 1066 medium (Life Technologies, NY, USA) 
supplemented with 8.3 mM glucose, 10 mM HEPES, 2 mM L-glutamine and 1% Penicilin/Streptomycin. 
As control served CMRL 1066 medium containing 10% FCS, 8.3 mM glucose, 10 mM HEPES, 2 mM 
L-glutamine and 1% Penicilin/Streptomycin.
Islets were cultured in a 24-well non-treated plate (Costar®, New York, USA). Each well contained 25 
free or encapsulated islets in 0.8 ml of CMRL 1066 medium and were incubated in control or low-nutrient 
condition combined with normoxia or hypoxia.
Measurement of specific danger/damage-associated molecular patterns (DAMPs). To quan-
tify the danger/damage-associated molecular patterns (DAMPs), ELISAs were used on supernatant 
of incubated islets. ELISAs for detecting High-Mobility Group Box 1 (HMGB1, Qayee-Bio, Shanghai, 
China), Heat Shock Protein 70 (HSP70, Donglin Sci & Tech, Wuxi/Jiangsu, China), double stranded 
DNA (dsDNA, BlueGene Biotech, Shanghai, China), and uric acid (Abcam® , Cambridge, UK) were 
performed according to standard protocols provided by the manufacturer.
Screening for immunostimulation and identification of pattern recognition receptor activa-
tion. To determine the immunostimulatory capacity elicited by free or encapsulated islets, samples 
of the supernatant of islet-cultures were taken on day 1 and 7. Also, islets were collected for confocal 
microscopy analysis. The samples for immunostimulatory capacity were co-incubated with different cell 
lines (InvivoGen, Toulouse, France) that express pattern recognition receptors (PRRs) under the control 
of a SEAP reporter gene inducible by the transcription factors NF-κ B/AP-125,26,44 and contained addi-
tional inserts for the co-signaling molecules CD14 and MD2 to facilitate TLR-mediated responses45. 
In addition, we applied a THP1 cell expressing a non-functional form of the TLR adapter MyD88 
(THP1-XBlue™ -defMyD).
THP1-XBlue™ -MD2-CD14 and -defMyD88 cells were suspended in fresh RPMI 1640 culture 
medium containing 2 mM L-glutamine, 1.5 g/l sodium bicarbonate, 4.5 g/l, 10 mM HEPES and 1.0 mM 
sodium pyruvate, and supplemented with 10% fetal bovine serum (deactivated phosphatases), 100 μ g/ml 
Normocin™ , Pen-Strep (50 U/ml–50 μ g/ml) at 1 × 106 cells/ml and plated in 96-well plates. Each well 
was stimulated with samples of supernatant from naked or encapsulated islets in control or starvation 
conditions and 20% or 1% of O2 and cultured overnight at 37 °C and 5% CO2. As positive controls, 
lipopolysaccharide from Escherichia coli K12 strain (LPS-EK Ultrapure 10 μ g/ml, InvivoGen, Toulouse, 
France) was used for the THP1-XBlue™ -MD2-CD14 cell line and L-Ala-γ -D-Glu-mDAP (Tri-DAP 
10 μ g/ml, InvivoGen,Toulouse, France) for theTHP1-XBlue™ -defMyD88 cell line. In both cell lines 
RPMI 1640 culture medium was used as a negative control. Production of SEAP was quantified by using 
QUANTI-Blue™ (InvivoGen, Toulouse, France) a medium for detection and quantification of alkaline 
phosphatase. QUANTI-Blue™ medium change to a purple- blue color in the presence of SEAP. An ali-
quot of QUANTI-Blue™ (200 μ l) was brought in a new flat bottom 96-well plate with 20 μ l of supernatant 
from the stimulated cell-lines for 45 min at 37 °C and SEAP activity, representing activation of NF-κ B/
AP-1, was measured at a wavelength of 650 nm on a VersaMax microplate reader (Molecular Devices 
GmbH, Biberach an der Riss, Germany) using SoftMax Pro Data Acquisition & Analysis Software15,25,40.
Confocal analysis. Apoptosis was measured using Annexin V, Alexa Fluor® (InvitroGen Life 
TechnologiesTM, NY, USA). Collected naked or encapsulated islets were incubated for 30 min with 
Annexin V (3 μ l per 1 ml of cell culture) at room temperature avoiding light. After incubation, the islets 
were washed five times with KRH. Fluorescent confocal microscopy was measured at an emission wave-
length of 665 nm using a Leica TCS SP2 AOBS confocal microscope (Wetzlar, Germany) equipped with 
an objective HC PL APO CS 10x/0,30, dry immersion, and working distance of 11 mm. Data were ana-
lyzed using Imaris® x64 version 7.6.4 software and ImageJ 1.47.
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Measurement of autophagy in islets. Autophagic cells were identified using a PremoTM Autophagy 
expression kit, time-resolved fluorescence resonance energy transfer of terbium-labeled LC3B antibodies 
(Tb/GFP TR-FRET LC3B) from Molecular Probes® (Life TechnologiesTM, NY, USA)27. As positive con-
trol we applied the lysosomal inhibitor chloroquine (CQ) (half-dilutions from 100-0 μ M) to block the 
turnover of autophagosomes. Islets cultured under control conditions (complete CMRL 1066, 10% FCS 
v/v, 20% O2) served as negative control.
The islets were tested after 30 min exposure to low-nutrition conditions and/or hypoxic conditions 
(CMRL 1066 without FCS, 1% O2) following the manufacturer protocol. The assay plate was read using 
a Thermo Scientific Varioskan® reader for fluorescence (MA, USA) with an excitation wavelength of 
332/12 nm, emission 1 of 488/12 nm, and emission 2 of 518/12 using 200 flashes for the acceptor channel 
(518 nm) and 100 flashes for the terbium channel (488 nm). For each well, the TR-FRET emission ratio 
(518 nm/488 nm) was calculated by dividing the acceptor emission value by the donor emission value. To 
normalize data, assay window values were determined by dividing the TR-FRET emission ration by the 
CQ-treated emission ratio values by the average emission ratio of the baseline control27.
Western blot. Human islets were lysed using a radio-immunoprecipitation assay (RIPA) buffer 10x 
(Millipore, The Netherlands) supplemented with protease inhibitors. The protein concentration was 
determined using the BCA (bicinchoninic acid) Protein Assay (Thermo scientific, MA USA). An equal 
amount of protein was loaded on a 10% polyacrylamide (PAA) gel, separated and transferred to a nitro-
cellulose Immobilon® -FM transfer membrane (Millipore, The Netherlands). The membrane was blocked 
with Odyssey® blocking buffer (Li-cor, The Netherlands) for 1 hr at room temperature and then incu-
bated with the primary antibody in 1x PBS with 0.1% Tween overnight at 4 °C. A caspase-3 human 
specific antibody (Cell Signaling Technology, Leiden, The Netherlands) and a caspase-9 human specific 
antibody (Cell Signaling Technology, Leiden, The Netherlands) were used to detect endogenous levels 
of full-length caspase-3 or − 9 (32 and 47 kDa respectively) and large fragments of caspase-3 or − 9. The 
membrane was washed with a phosphate-buffer saline with Tween (PBS-T) and incubated for 1 hr with 
the secondary antibody IRDye 800CW (Odyssey, Li-cor, The Netherlands) in the dark. Finally, β -actin 
rabbit antibody (Cell Signaling Technology, Leiden, The Netherlands) was used as housekeeping protein. 
Primary antibodies were used at a dilution of 1:1000, and secondary antibody at a dilution of 1:2000.
Nuclei isolation and DNA content measurement. A Nuclei EZ prep nuclei isolation kit 
(Sigma-Aldrich, MO, USA) was used to isolate nuclei and count only nuclear DNA in order to quantify 
the amount of live cells after the different culture conditions. Islets were centrifuged at 500 G for 5 min. 
The supernatant was removed and the cells were washed with PBS the supernatant was discarded and 
1 ml of cold Nuclei EZ prep nuclei isolation lysis buffer was added. Cells were vortexed and incubated 
at 4 °C for 5 min. The remaining cellular material was centrifuged at 500 G for 5 min to sediment nuclei 
and supernatant with other cellular components was discarded. Isolated nuclei were subsequently used 
to quantify the DNA content.
Quantification of DNA in islet nuclei was performed using a Quant-iT™ PicoGreen® dsDNA Assay 
Kit (Live Technologies, The Netherlands)46. The nuclei were incubated with 100 μ l of TE buffer (200 mM 
Tris-HCl, 20 mM EDTA, pH 7.5). After adding the solution nuclei were sonicated for 10 sec at 30% power 
and plated in a 96 well-plate. Reagent for fluorescent detection was prepared by making a 200-fold dilution 
of the Quanti-iT PicoGreen reagent in TE buffer and addition of 100 μ l to the samples. Quantification of 
dsDNA was done in a fluorescence microplate reader Thermo Scientific Varioskan® (Thermo Scientific, 
MO, USA) at excitation and emission wavelengths of 480 and 520 nm respectively.
Statistical analysis. Values are expressed as median ± IQR. Statistical comparisons were performed 
using the Mann–Whitney U test to compare the outcomes of the nonparametric, unmatched treatments 
of controls and islets cultured under low nutrient conditions. Values of p < 0.05 were considered to be 
statistically significant.
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